Volta
Cost-effectiveness analysis of different COVID-19 screening strategies based on rapid or laboratory-based SARS-CoV-2 antigen testing
Unknown authors
· 2023
hash_id: 627712f9d35bb89acf2e490849e12b1268154e387cd15f6a0c3c3ee1a4e468e9
· DOI: 10.1515/cclm-2023-0164
Article Cost-effectiveness analysis of different COVID-19 screening strategies based on rapid or laboratory-based SARS-CoV-2 antigen testing was published on August 1, 2023 in the journal Clinical Chemistry and Laboratory Medicine (CCLM) (volume 61, issue 9).
Reference & gravity metrics
Citations
0
Citations / yr
0.00
RCR
Mass
0.00
Depth
0.00
Momentum
0.000
Burn rate
0.00 ATP/day
Start price
25.00 ATP
Secondary-market trade history
No secondary-market trades recorded for this Volta yet.
References (0)
No outbound references recorded.
Cited by (1)
| Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection | secondary |